Filter Results
:
(585)
Show Results For
-
All HBS Web
(2,471)
- Faculty Publications (585)
Show Results For
-
All HBS Web
(2,471)
- Faculty Publications (585)
Page 1 of
585
Results
→
- March 2024
- Teaching Note
Sonder Holdings Inc.: Using Technology to Solve Hospitality’s Frictions
By: John A. Deighton and Leora Kornfeld
Digital disruption is challenging the hospitality industry. Traditional hotels face competition from platforms, most visibly Airbnb but also the homeshare divisions of online travel agencies such as Expedia and Booking.com, that bring new kinds of short-term...
View Details
- March 2024
- Case
Funderbeam: Teaming Up or Going Alone?
By: Paul A. Gompers, Elena Corsi and Orna Dan
Estonian funding and trading platform Funderbeam debates whether to accept a merger offer from an Irish company or remain independent and seek alternate funding.
View Details
- March 2024
- Case
East Rock Capital: 'Talent is the Best Asset Class'
By: Boris Groysberg, Sarah L. Abbott and Izzy Yeoh
Adam Shapiro and Graham Duncan launched East Rock Capital, LLC in 2006 with a seed investment from Stuart Miller, executive chairman of Lennar Corporation. East Rock managed long-term assets for high-net-worth families, primarily working with external managers who had...
View Details
- 2024
- Article
Beyond the 510(k): The Regulation of Novel Moderate-Risk Medical Devices, Intellectual Property Considerations, and Innovation Incentives in the FDA’s De Novo Pathway
By: Mateo Aboy, Cristina Crespo and Ariel Stern
Moderate-risk medical devices constitute 99% of those that have been regulated by the U.S. Food and Drug Administration (FDA) since it gained authority to regulate medical technology nearly five decades ago. This article presents an analysis of the interaction between...
View Details
Keywords:
Governing Rules, Regulations, and Reforms;
Health Care and Treatment;
Technology Adoption;
Technological Innovation;
Safety;
Medical Devices and Supplies Industry;
United States
Aboy, Mateo, Cristina Crespo, and Ariel Stern. "Beyond the 510(k): The Regulation of Novel Moderate-Risk Medical Devices, Intellectual Property Considerations, and Innovation Incentives in the FDA’s De Novo Pathway." Art. 29. npj Digital Medicine 7 (2024).
- 2024
- Report
Overcoming Barriers to Resolving Gaza and Beyond
As of early January 2024, discussion of the Gaza war heavily focuses on its humanitarian costs, cease fire possibilities, hostage prospects, and “day after” options. Yet what longer-term strategy guides actions on these vital issues while offering a more positive...
View Details
Sebenius, James K. "Overcoming Barriers to Resolving Gaza and Beyond." Report, Belfer Center for Science and International Affairs, January 2024.
- January 2024
- Case
ECOALF: Fashion for the Future
By: Elizabeth A. Keenan, Diego Aparicio, Carlota Moniz and María José Satrústegui
ECOALF, a Spanish fashion brand and sustainability pioneer, aimed to tackle the industry's challenges of excessive consumption and production. The brand's mission was to create timeless apparel exclusively from recycled and eco-responsible materials, matching the...
View Details
Keywords:
Business Growth and Maturation;
Business Model;
Decisions;
Business Earnings;
Profit;
Growth and Development Strategy;
Communication Intention and Meaning;
Values and Beliefs;
Mission and Purpose;
Competition;
Climate Change;
Environmental Sustainability;
Social Marketing;
Marketing Channels;
E-commerce;
Fashion Industry;
Spain;
Germany;
Italy;
Europe;
United States
- January 2024 (Revised February 2024)
- Case
TPG Rise Climate: Deploying 'Climate Capital'
By: Vikram S. Gandhi, David Allen, Sarah Mehta and Shannon Roche
This case is about TPG Rise Climate, a $7.3 billion climate impact fund launched in 2021 by alternative asset manager TPG. Climate investing is a complex, capital-intensive endeavor; entering it has forced TPG to think and act differently. Relative to other funds, Rise...
View Details
Keywords:
Energy;
Environmental Management;
Finance;
Government and Politics;
Ownership;
Science;
Value;
Financial Services Industry;
California;
San Francisco;
New York (city, NY)
Gandhi, Vikram S., David Allen, Sarah Mehta, and Shannon Roche. "TPG Rise Climate: Deploying 'Climate Capital'." Harvard Business School Case 824-077, January 2024. (Revised February 2024.)
- January 2024
- Article
A Cost Model for a Low Threshold Clinic Treating Opioid Use Disorder
By: Sarah E. Wakeman, Elizabeth Powell, Syed Shehab, Grace Herman, Laura Kehoe and Robert S. Kaplan
The US fee-for-service payment system under-reimburses clinics offering access to comprehensive treatments for opioid use disorder (OUD). The funding shortfall limits a clinic’s ability to expand and improve access, especially for socially marginalized patients with...
View Details
Wakeman, Sarah E., Elizabeth Powell, Syed Shehab, Grace Herman, Laura Kehoe, and Robert S. Kaplan. "A Cost Model for a Low Threshold Clinic Treating Opioid Use Disorder." Journal of Behavioral Health Services & Research 51, no. 1 (January 2024): 22–30.
- 2024
- Working Paper
Bootstrap Diagnostics for Irregular Estimators
By: Isaiah Andrews and Jesse M. Shapiro
Empirical researchers frequently rely on normal approximations in order to summarize and communicate uncertainty about their findings to their scientific audience. When such approximations are unreliable, they can lead the audience to make misguided decisions. We...
View Details
Andrews, Isaiah, and Jesse M. Shapiro. "Bootstrap Diagnostics for Irregular Estimators." NBER Working Paper Series, No. 32038, January 2024.
- 2023
- Working Paper
Debiasing Treatment Effect Estimation for Privacy-Protected Data: A Model Auditing and Calibration Approach
By: Ta-Wei Huang and Eva Ascarza
Data-driven targeted interventions have become a powerful tool for organizations to optimize business outcomes
by utilizing individual-level data from experiments. A key element of this process is the estimation
of Conditional Average Treatment Effects (CATE), which...
View Details
Huang, Ta-Wei, and Eva Ascarza. "Debiasing Treatment Effect Estimation for Privacy-Protected Data: A Model Auditing and Calibration Approach." Harvard Business School Working Paper, No. 24-034, December 2023.
- 2022
- Working Paper
Why Do Index Funds Have Market Power? Quantifying Frictions in the Index Fund Market
By: Zach Y. Brown, Mark Egan, Jihye Jeon, Chuqing Jin and Alex A. Wu
Index funds are one of the most common ways investors access financial markets and are perceived to be a transparent and low-cost alternative to active investment management. Despite these purported virtues of index fund investing and the introduction of new products...
View Details
Keywords:
Mutual Funds;
Passive Investing;
Asset Management;
Financial Markets;
Investment Funds;
Financial Management;
Financial Services Industry;
United States
Brown, Zach Y., Mark Egan, Jihye Jeon, Chuqing Jin, and Alex A. Wu. "Why Do Index Funds Have Market Power? Quantifying Frictions in the Index Fund Market." Harvard Business School Working Paper, No. 24-019, October 2023. (NBER Working Paper Series, No. 31778, October 2023.)
- October 2023
- Article
Finding New Business and Developing Relevant Sales Capabilities
There are few alternatives to growth for most companies. It’s the rare firm whose goal involves getting smaller and, for employees, there is a strong correlation between their company’s growth rate, promotion opportunities, and job satisfaction. But a growth strategy...
View Details
Cespedes, Frank V. "Finding New Business and Developing Relevant Sales Capabilities." Top Sales Magazine (October 2023), 24–25.
- September 2023
- Teaching Note
Roche: ESG and Access to Healthcare
By: George Serafeim
Teaching Note for HBS Case No. 123-075. In May 2022, Roche Group, one of the largest healthcare companies in the world, hosted its first ESG investor event focused exclusively on its efforts to impact access to healthcare. While Roche had recently set an ambitious goal...
View Details
- September 2023 (Revised January 2024)
- Case
AI21 Labs in 2023: Strategy for Generative AI
By: David Yoffie, Orna Dan and Elena Corsi
Israeli generative artificial intelligence company AI21 Labs was founded in 2017 to realize the vision of true machine intelligence. It sought to reinvent writing and reading and in 2020 it launched Wordtune, an app using GenAI software to offer alternate text...
View Details
Keywords:
Decision Making;
AI and Machine Learning;
Innovation Strategy;
Growth and Development Strategy;
Applications and Software;
Competitive Strategy;
Technology Industry;
Israel
Yoffie, David, Orna Dan, and Elena Corsi. "AI21 Labs in 2023: Strategy for Generative AI." Harvard Business School Case 724-383, September 2023. (Revised January 2024.)
- 2023
- Working Paper
Global Supply Chains: The Looming 'Great Reallocation'
By: Laura Alfaro and Davin Chor
Global supply chains have come under unprecedented stress as a result of U.S.-China trade tensions, the COVID-19 pandemic, and geopolitical shocks. We document shifts in the pattern of U.S. participation in global value chains over the last four decades, in terms of...
View Details
Alfaro, Laura, and Davin Chor. "Global Supply Chains: The Looming 'Great Reallocation'." Harvard Business School Working Paper, No. 24-012, August 2023. (in proceedings Jackson Hole Symposium, 2023 (also NBER WP 31661). See feature in NBER Digest, Nov (2023): Economics, Politics, and the Evolution of Global Supply Chains.)
- September 2023
- Article
Addressing Vaccine Hesitancy: Experimental Evidence from Nine Countries during the COVID-19 Pandemic
By: Vincenzo Galasso, Vincent Pons, Paola Profeta, Martin McKee, David Stuckler, Michael Becher, Sylvain Brouard and Martial Foucault
We study the impact of public health messages on intentions to vaccinate and vaccination uptakes, especially among hesitant groups. We performed an experiment comparing the effects of egoistic and altruistic messages on COVID-19 vaccine intentions and behaviour. We...
View Details
Keywords:
COVID-19;
Vaccination;
Vaccine Hesitancy;
Information Campaigns;
Health Pandemics;
Behavior;
Information
Galasso, Vincenzo, Vincent Pons, Paola Profeta, Martin McKee, David Stuckler, Michael Becher, Sylvain Brouard, and Martial Foucault. "Addressing Vaccine Hesitancy: Experimental Evidence from Nine Countries during the COVID-19 Pandemic." BMJ Global Health 8, no. 9 (September 2023).
- July 2023 (Revised August 2023)
- Case
Revenue Recognition at Stride Funding: Making Sense of Revenues for a Fintech Startup
By: Paul M. Healy and Jung Koo Kang
The case explores the challenges of revenue recognition and financial reporting for Stride Funding (Stride), a fintech startup that has disrupted the student loan market. Stride leveraged proprietary machine learning and financial models to underwrite alternative...
View Details
Keywords:
Revenue Recognition;
Financial Reporting;
Entrepreneurial Finance;
Business Startups;
Growth and Development Strategy;
Governance Compliance;
Accrual Accounting;
Financial Services Industry;
United States
Healy, Paul M., and Jung Koo Kang. "Revenue Recognition at Stride Funding: Making Sense of Revenues for a Fintech Startup." Harvard Business School Case 124-015, July 2023. (Revised August 2023.)
- July 13, 2023
- Article
Threads Foreshadows a Big—and Surprising—Shift in Social Media
By: Scott Duke Kominers and Liang Wu
Threads, Meta’s Twitter competitor, has become the fastest downloaded app in history. One of the reasons for this is because it allows users to port over their profiles and follows from the already popular social media platform Instagram, also owned by Meta—a feature...
View Details
Keywords:
Decentralization;
Twitter;
Facebook;
Instagram;
Crypto Economy;
Blockchain;
Network;
Industrial Organization;
Competition;
Open Innovation;
Open Platforms;
Open Source Innovation;
Social Networks;
Social Media;
Applications and Software;
Information Technology Industry
Kominers, Scott Duke, and Liang Wu. "Threads Foreshadows a Big—and Surprising—Shift in Social Media." Harvard Business Review Digital Articles (July 13, 2023).
- July 2023
- Article
Deep Responsibility and Irresponsibility in the Beauty Industry
By: Geoffrey Jones
This article employs the concept of deep responsibility to assess the social responsibility of the beauty industry over time. It shows that many of today’s problems with the industry have deep historical roots. Products have too many ingredients that are potential...
View Details
Keywords:
Business History;
Corporate Social Responsibility and Impact;
Beauty and Cosmetics Industry
Jones, Geoffrey. "Deep Responsibility and Irresponsibility in the Beauty Industry." Entreprises et histoire 111, no. 2 (July 2023): 113–125.
- June 2023
- Supplement
Roche: ESG and Access to Healthcare
By: George Serafeim
In May 2022, Roche Group, one of the largest healthcare companies in the world, hosted its first ESG investor event focused exclusively on its efforts to impact access to healthcare. While Roche had recently set an ambitious goal to double the number of patients that...
View Details
Keywords:
ESG (Environmental, Social, Governance) Performance;
Sustainable Finance;
Growth Strategy And Execution;
Sustainability Targets;
Impact Evaluation;
Healthcare Access;
Healthcare Innovation;
Healthcare Systems;
Healthcare Operations;
Finance;
Strategy;
Health Testing and Trials;
Health Care and Treatment;
Growth Management;
Measurement and Metrics;
Innovation Strategy;
Corporate Social Responsibility and Impact;
Health Industry;
Pharmaceutical Industry;
Switzerland;
North America;
Europe;
Asia;
Latin America;
Africa
Serafeim, George. "Roche: ESG and Access to Healthcare." Harvard Business School Multimedia/Video Supplement 123-713, June 2023.